BRIEF-Teva Pharmaceutical reaffirms 2013 outlook

Thu Feb 7, 2013 8:39am EST

Feb 7 (Reuters) - Teva Pharmaceutical Industries Chief Financial Officer Eyal Desheh says:

* Reiterates 2013 revenue forecast $19.5-$20.5 bln, adjusted EPS $4.85-$5.15

FILED UNDER: